Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy

Owing to their professional antigen-presenting capacity and unique potential to induce tumor antigen-specific T cell immunity, dendritic cells (DCs) have attracted much interest over the past decades for therapeutic vaccination against cancer. Clinical trials have shown that the use of tumor antigen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Anguille, Sébastien, Lion, Eva, Van den Bergh, Johan, Van Acker, Heleen H, Willemen, Yannick, Smits, Evelien L, Van Tendeloo, Viggo F, Berneman, Zwi N
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906362/
https://ncbi.nlm.nih.gov/pubmed/23778748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25373
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars